Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Crohn’s Disease Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Crohn’s Disease Drugsmarket, defines the market attractiveness level of Crohn’s Disease Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Crohn’s Disease Drugs industry, describes the types of Crohn’s Disease Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Crohn’s Disease Drugs market and the development prospects and opportunities of Crohn’s Disease Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Crohn’s Disease Drugs market in Chapter 13.
By Player:
Eli Lilly
Ferring
Bristol-Myers Squibb
Hoffman-La Roche
Amgen
AbbVie
UCB
Bayer AG
Takeda Pharmaceutical
Pfizer
By Type:
Anti-Inflammatory
Immune system suppressors
Antibiotics
Others
By End-User:
Hospitals
Clinics
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Crohn’s Disease Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Crohn’s Disease Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Crohn’s Disease Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Crohn’s Disease Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Crohn’s Disease Drugs Market Analysis and Outlook to 2022
-
7.1 Global Crohn’s Disease Drugs Consumption (2017-2022)
-
7.2 United States Crohn’s Disease Drugs Consumption (2017-2022)
-
7.3 Europe Crohn’s Disease Drugs Consumption (2017-2022)
-
7.4 China Crohn’s Disease Drugs Consumption (2017-2022)
-
7.5 Japan Crohn’s Disease Drugs Consumption (2017-2022)
-
7.6 India Crohn’s Disease Drugs Consumption (2017-2022)
-
7.7 South Korea Crohn’s Disease Drugs Consumption (2017-2022)
8 Region and Country-wise Crohn’s Disease Drugs Market Analysis and Outlook to 2028
-
8.1 Global Crohn’s Disease Drugs Consumption Forecast (2022-2028)
-
8.2 United States Crohn’s Disease Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Crohn’s Disease Drugs Consumption Forecast (2022-2028)
-
8.4 China Crohn’s Disease Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Crohn’s Disease Drugs Consumption Forecast (2022-2028)
-
8.6 India Crohn’s Disease Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Crohn’s Disease Drugs Consumption Forecast (2022-2028)
9 Global Crohn’s Disease Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Crohn’s Disease Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anti-Inflammatory Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immune system suppressors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Antibiotics Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Crohn’s Disease Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hospitals Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Crohn’s Disease Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Crohn’s Disease Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anti-Inflammatory Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immune system suppressors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Crohn’s Disease Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Hospitals Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Crohn’s Disease Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Crohn’s Disease Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Crohn’s Disease Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Crohn’s Disease Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Crohn’s Disease Drugs Market Competitive Analysis
-
14.1 Eli Lilly
-
14.1.1 Eli Lilly Company Details
-
14.1.2 Eli Lilly Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly Crohn’s Disease Drugs Product and Service
-
14.2 Ferring
-
14.2.1 Ferring Company Details
-
14.2.2 Ferring Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Ferring Crohn’s Disease Drugs Product and Service
-
14.3 Bristol-Myers Squibb
-
14.3.1 Bristol-Myers Squibb Company Details
-
14.3.2 Bristol-Myers Squibb Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Crohn’s Disease Drugs Product and Service
-
14.4 Hoffman-La Roche
-
14.4.1 Hoffman-La Roche Company Details
-
14.4.2 Hoffman-La Roche Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Hoffman-La Roche Crohn’s Disease Drugs Product and Service
-
14.5 Amgen
-
14.5.1 Amgen Company Details
-
14.5.2 Amgen Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Amgen Crohn’s Disease Drugs Product and Service
-
14.6 AbbVie
-
14.6.1 AbbVie Company Details
-
14.6.2 AbbVie Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AbbVie Crohn’s Disease Drugs Product and Service
-
14.7 UCB
-
14.7.1 UCB Company Details
-
14.7.2 UCB Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 UCB Crohn’s Disease Drugs Product and Service
-
14.8 Bayer AG
-
14.8.1 Bayer AG Company Details
-
14.8.2 Bayer AG Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bayer AG Crohn’s Disease Drugs Product and Service
-
14.9 Takeda Pharmaceutical
-
14.9.1 Takeda Pharmaceutical Company Details
-
14.9.2 Takeda Pharmaceutical Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Takeda Pharmaceutical Crohn’s Disease Drugs Product and Service
-
14.10 Pfizer
-
14.10.1 Pfizer Company Details
-
14.10.2 Pfizer Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Pfizer Crohn’s Disease Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Crohn’s Disease Drugs
-
Figure Crohn’s Disease Drugs Picture
-
Table Global Crohn’s Disease Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Crohn’s Disease Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Crohn’s Disease Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Crohn’s Disease Drugs Consumption by Country (2017-2022)
-
Figure United States Crohn’s Disease Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Crohn’s Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Crohn’s Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Crohn’s Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Crohn’s Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Crohn’s Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Crohn’s Disease Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Crohn’s Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Crohn’s Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Crohn’s Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Crohn’s Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Crohn’s Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Crohn’s Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-Inflammatory Consumption and Growth Rate (2017-2022)
-
Figure Global Immune system suppressors Consumption and Growth Rate (2017-2022)
-
Figure Global Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Inflammatory Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immune system suppressors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Crohn’s Disease Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Crohn’s Disease Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Crohn’s Disease Drugs Product and Service
-
Table Ferring (Foundation Year, Company Profile and etc.)
-
Table Ferring Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ferring Crohn’s Disease Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Crohn’s Disease Drugs Product and Service
-
Table Hoffman-La Roche (Foundation Year, Company Profile and etc.)
-
Table Hoffman-La Roche Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hoffman-La Roche Crohn’s Disease Drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Crohn’s Disease Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Crohn’s Disease Drugs Product and Service
-
Table UCB (Foundation Year, Company Profile and etc.)
-
Table UCB Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Crohn’s Disease Drugs Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Crohn’s Disease Drugs Product and Service
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Crohn’s Disease Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Crohn’s Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Crohn’s Disease Drugs Product and Service
-
